Sign in
Taking people in United StatesEarly phase 1

Studies how nerves raise blood pressure in obesity-linked high blood pressure

Studies nerve signals and blood vessel response in adults with obesity and high blood pressure.

Key facts

Who runs it
University of Texas Southwestern Medical Center
Where
Dallas, United StatesSee the site
Trial code
Registry title
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Status
Recruiting
Phase
Early phase 1
People taking part
100 people, planned
Started
18 Jul 2021
Expected to end
31 Dec 2026
Type of study
Interventional, 4 groups
Treatments tested
  • Neuropeptide Y
Record updated
3 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 55 in four groups: healthy controls, people with high blood pressure, people with obesity, and people with both obesity and high blood pressure.

Age
18 to 55 years
Sex
All sexes can join.
Disease stage
Four groups. Control: BMI under 30. Hypertensive: BMI under 30 and high blood pressure confirmed by 24-hour ambulatory blood pressure monitoring. Obese: BMI over 30. Obese-hypertensive: BMI over 30 and high blood pressure confirmed by 24-hour ambulatory blood pressure monitoring.

Main reasons for not taking part

  • Other significant cardiovascular disease
  • Kidney disease
  • History of smoking
  • Diabetes

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Control - BMI<30, age 18-55
  • Hypertensive - BMI<30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring Obese- BMI>30, age 18-55 Obese-hypertensive- BMI>30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring

Who cannot take part

  • All groups - presence of other significant cardiovascular disease, renal disease, history of smoking, diabetes,

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 55 years old?

Where in United States

  • University of Texas Southwestern Medical CenterDallas, United StatesContact: CHristopher HearonTaking people

About the trial

What the trial wants to find out

The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.

The 4 groups in the trial

  • Healthy ControlTreatment being tested

    Healthy age matched controls with no history of cardiovascular disease and normal bodyweight

    Treatment: Neuropeptide Y

  • HypertensiveTreatment being tested

    Hypertensive adults who are not obese

    Treatment: Neuropeptide Y

  • ObeseTreatment being tested

    Obese adults who are not hypertensive

    Treatment: Neuropeptide Y

  • Obese-hypertensiveTreatment being tested

    Obese adults who are being treated for hypertension

    Treatment: Neuropeptide Y

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension
Plain-language title
Studies how nerves raise blood pressure in obesity-linked high blood pressureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04838678, who can take part
Record updated
3 September 2026